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A B S T R A C T
A 49-year-old woman presented for hirsutism, deep voice and hypertension. Ultrasonography (US) revealed a solitary
tumor mass, eight cm in size, of the right adrenal gland. Laboratory tests showed it to be a hormonally active, androgen
secreting tumor (elevated testosterone level), which was consistent with the clinical picture of the disease. After histopa-
thological analysis tumor was signed out as adrenocortical carcinoma, a low risk carcinoma according to Weiss’ classifi-
cation. One year later on regular follow up, US revealed a suspicious growth measuring 65x43 mm in the projection of
the lower pole of the right kidney. The finding was verified by computerized tomography and the patient was reoperated
on. Exploration revealed secondary growth in the region of greater omentum, without infiltration of adjacent organs.
Histopathologic analysis confirmed metastatic ACC. 8 months after the second operation and after 6 chemotherapy cycles
according to EAP protocol, control CT showed enlarged para-aortic lymph nodes and a node along the upper pole of the
right kidney. Cytologic puncture was performed. Cytologic opinion was recidive of primary malignant disease. ACC is a
rare malignant epithelial tumor of adrenal cortical cells, with high malignant potential. Morphologically (histopa-
thology and cytology), differential diagnosis includes adenoma on the one hand, and renal cell carcinoma (RCC) and
hepatocellular carcinoma (HCC) on the other hand. A combined evaluation of clinical features, size or weight, micro-
scopic appearance, immunohistochemical and molecular genetic data is necessary to ensure a correct diagnosis. The
purpose of this case report is to present clinical and cytomorphologic features of our case of adrenocortical carcinoma
which is very rare in cytology practice.
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Introduction
Adrenal cortical carcinoma is a malignant epithelial
tumor of adrenal cortical cells. The incidence is about 0.1
cases per 100,000, with predilection for females. It has bi-
modal age distribution, with peak in first and fifth de-
cade. Approximately half of all ACCs are hormonally
functional. The most common presentation is associated
with glucocorticoid (Cushing syndrome) and androgen
(virilization in women) oversecretion by the tumor. Mi-
neralocorticoids may contribute a severe state of mine-
ralocorticoid excess with high blood pressure and hypo-
kalaemia. A significant subset of ACCs secretes only
androgens and some show no clinical features of hor-
mone excess1. Adrenal cortical carcinomas (ACCs) tend
to be large (90% are greater than 50–60 mm). Necrosis,
hemorrhage and calcifications are common1,2. Displace-
ment or involment of adjacent organs, as well as hepatic
and nodal metastases are also present frequently1. ACCs
have architectural and cytological features that generally
recapitulate the normal adrenal cortex. The most com-
mon architectural pattern is that of patternless sheets of
cells interrupted by a fine sinusoidal network. Broad
trabecule or large nests of cells may be seen. Cyto-
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logically, ACCs are composed of varying numbers of cells
with eosinophilic or bubbly clear cytoplasm. Nuclear
atypia varies from non-existent to highly pleomorphic.
Mitotic rate also varies widely1. The FNA smears of
ACCs are usually rich in cells. With a few exceptions, the
experience with these tumors is limited to high grade
malignant tumors. Therefore, in most cases the smear
pattern is that of a high grade malignant tumor, whereas
well differentiated tumors are rarely seen.
The smears of well differentiated tumors contain rela-
tively uniform tumor cells, occurring either singly or in
loose clusters, with abundant, eosinophilic granular cyto-
plasm, relatively large, often eccentric, but uniform nu-
clei with a coarse chromatin pattern and prominent nu-
cleoli. Capillary vessels may be occasionally observed
within the cell clusters. Foci of anisonucleosis may be ob-
served among the monotonous population of tumor cells.
The resemblance to the grade 2 or 3 granular cell variant
of RCC is inescapable. Poorly differentiated cortical car-
cinomas yield large anaplastic malignant tumor cells of
variable sizes, singly or in loose clusters. Many of the
large cells are multinucleated. The nuclei are very pleo-
morphic and contain prominent nucleoli. Abnormal mi-
toses can be seen. Such smear patterns are not specific,
and may be observed in any poorly differentiated tumor
with giant cells. Somewhat similar smear pattern may
also occur in pheochromocytoma2. Immunohistochemical
profiling may be helpful in separating ACCs from renal
cell and hepatocellular carcinoma, adrenal medullary
and metastatic tumors.
Immunoreactivity for alpha-inhibin and A 103 anti-
-Melan A antibody is sensitive but not specific for ACCs.
ACCs are variably reported to be negative to weakly posi-
tive for cytokeratin and negative for epithelial mem-
brane antigen, carcinoembryonic antigen and glycopro-
tein HMFG-2. They are negative for chromogranin A,
the most reliable marker for discriminating them from
adrenal medullary tumors. Other neural markers are
variably positive. The major differential diagnosis is with
adrenal cortical adenoma. Useful histological criteria are
mitotic rate and the presence of vascular or capsular in-
vasion. The MIB-1/Ki-67 labeling index may be of value
and usually averages about 5–20%. Findings favoring
metastatic carcinoma rather than ACCs include bilate-
rality and evidence of any glandular, squamous or small
cell histology. The five-year survival rate is 50–70%1.
Case Report
A 49-year old woman presented for hirsutism, deep
voice and hypertension. The hypertension was first ob-
served 15 years ago (200/100 mmHg) and was treated
with antihypertensives and controlled regularly. Ultra-
sound examinations of abdomen were performed once or
twice a year. 11 years ago a patient had a rupture of cere-
bral blood vessel aneurysm which was treated surgically.
6 years ago, an angiomyolipoma of the right kidney was
discovered ultrasonographically, and confirmed by com-
puted tomography. About half a year ago, patient noticed
hirsutism of the upper and lower limbs, deep voice and
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Fig. 1. FNA smear of adrenocortical carcinoma (May-Grünwald- Giemsa staining, x1000): a) noncohesive malignant large, pleomor-
phic cells, b) cells with polymorphic, hyperchromic, irregular nuclei, c) large nuclei with prominent nucleoli, perinucleolar halo and




higher arterial blood pressure values despite the regular
antihypertensive therapy. Ultrasonography revealed a
solitary tumor mass of right adrenal gland, 78x65 mm in
size. An angiomyolipoma of the lower pole of right kidney
was also revealed. Laboratory tests showed increased
testosterone level of 24.5 nmol/L (reference value is less
than 7). Total metanephrine and vanilmandelic acid lev-
els were within normal limits. These findings suggested
hormonally active, androgen secreting tumor. Surgical
treatment was indicated and performed. Resected tumor
tissue was paraffin-embedded and hematoxylin-and- -eo-
sin-stained slides were analyzed. After histopathological
analysis tumor was signed out as adrenocortical carci-
noma, a low risk carcinoma according to Weiss classifica-
tion. Macroscopically, tumor was soft, yellow- -brown,
with areas of necrosis and hemorrhage. Histologically,
tumor consisted of widely anastomosing trabecular for-
mation with delicate, cleft-like vascular canals. However,
in serial cuts, areas of irregular stripes of pleomorphic
tumor cells within abundant mixoid stroma were pres-
ent. More than 75% cells had eosinophilic cytoplasm,
partly with polymorphic, hyperchromatic, irregular, lar-
ge nuclei with mitoses (less than 5 per 10 HPF), and few
atypical mitoses. Surface was covered with thin fibrous
capsule, and partly with atrophic adrenal tissue. There
was no clearly visible vascular invasion, but capsular in-
vasion was found. No extension to adjacent adipose tis-
sue and lymph nodes was observed. Immunohistoche-
mical analysis showed vimentin, NSE, synaptophysin
(+/–) positivity, and NF, chromogranin, EMA and CK
(AE1/AE3) negativity. Ki-67 positivity was seen in more
than 50% of tumor cells. An angiomyolipoma of the right
kidney was operated and histopathologically examinated
at the same time.
One year later, on regular follow up US study, a suspi-
cious growth was diagnosed in the projection of the right
kidney. Computed tomography showed a homogenous,
sharply demarcated tumor mass, 65x43 mm in size, in
the right lower hemiabdomen between the small intes-
tine convolutions. Surgical procedure was performed and
a part of greater omentum with encapsulated tumor
mass was extirpated. Macroscopically, tumor was sharply
demarcated, soft, yellow-brown, with areas of necrosis.
Histopathological analysis revealed diagnosis of meta-
static adrenal cortical carcinoma. 8 months after second
operation and 6 chemotherapy cycles according to EAP
protocol, control CT showed a tumor mass, 24x20 mm in
size, along the upper pole of the right kidney and en-
larged para-aortic lymph node, 28 mm in greatest diame-
ter. US guided fine needle aspiration of the tumor mass
in the projection of the upper pole of the right kidney was
performed. The yielded material was placed and smeared
on slides, air-dried and May-Grünwald-Giemsa (MGG)
stained. Cytologic analysis showed numerous large tu-
mor cells, individual and in papillary clusters, with poly-
morphic, hyperchromic, irregular nuclei, prominent nu-
cleoli with perinucleolar halo, bi- and multinucleation
and abundant, homogenous, pale basophilic cytoplasm
(Figures 1a-d). Tumor cells were positive for vimentin,
NSE, Ki-67, synaptophysin and epithelial markers
(BerEP4 and epithelial membrane antigen, Figures 2a
and b). Surgical treatment and adjuvant radiotherapy of
recidive was proposed. Histopathological analysis re-
vealed diagnosis of recidivant adrenocortical carcinoma
within subdiaphragmal, perirenal and paraaortal lymph
nodes and VII liver segment. Tumor tissue was not found
in right kidney, urether and renal artery and vein. De-
spite all supportive therapy the patient died.
Discussion
Virilizing adrenal carcinoma is a very rare disease4–6.
The diagnosis of ACC is often difficult, because this tu-
mor may present with direct extension into adjacent re-
nal parenchyma or with metastatic disease7. ACC can be
diagnosed by US, CT or MRI. These radiological tech-
niques in the absence of spread cannot distinguish a ma-
lignant from benign process6. Percutaneous fine needle
aspiration cytology under CT or US may be useful in re-
current disease and particularly to exclude metastasis.
Adrenocortical neoplasms have been divided into ade-
nomas and carcinomas. The bias toward high grade ma-
lignant tumors in cytologic material is presumably a re-
sult of clinical case selection for FNA. Many tumors can
be easily placed into one category or another, but cases
exist for which the distinction is difficult and to some ex-
tent arbitrary. Adenomas tend to be smaller, more ho-
mogenous and lacking hemorrhage and necrosis. Weiss
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Fig. 2. FNA of adrenocortical carcinoma, positive immunocytochemical stain (LSAB x1000) for a) NSE and b) vimentin.
b)a)
listed the following microscopic criteria as a suggestive of
malignancy in an adrenocortical tumor: nuclear grade III
or IV, mitotic rate greater than 5 per 50 high-power
fields, atypical mitoses, paucity or absence of clear cells,
diffuse architecture, necrosis, capsular and vascular in-
vasion. Immunohistochemically, adrenal cortical adeno-
mas show a great expression of low-molecular-weight
keratins and a lesser expression of vimentin that ACC. A
combined evaluation of clinical features, size or weight,
microscopic appearance, immunohistochemical and mo-
lecular genetic data is necessary.
The second important differential diagnosis is be-
tween ACC and renal cell carcinoma, which can invade
adrenal gland. Microscopically, these two tumors resem-
ble each other a great deal. Features favoring the diagno-
sis of renal cell carcinoma are the presence of glands and
abundant cytoplasmic glycogen, but neither is patho-
gnomonic. Perhaps the most important difference is cy-
toplasmic vacuolization which is present in RCC, but not
in adrenocortical carcinoma. Immunohistochemically,
strong positivity for cytokeratin, EMA, CD 10 and Lewis
blood group isoantigen favors RCC. Positivity for inhibin,
A103, Melan-A and synaptophysin favors ACC. The third
differential diagnosis is adrenomedullary tumor which is
more likely if chromogranin reactivity is present3. Adre-
nocortical carcinoma can have overlapping histological
features with hepatocellular carcinoma. Staining for in-
hibin and Melan-A is observed in adrenal cortical tumors
but not in HCC8–10. Inhibin is expressed in around 70 %
of adrenocortical carcinomas and Melan-A in 50–60%.
The sensitivity can be improved to more than 80% by
combination of both antibodies8,11. Also, CEA is not ex-
pressed in adrenocortical carcinoma. Most adrenocor-
tical tumors are negative for keratin while hepatocellular
carcinoma is positive for CK 8 and CK 188.
Conclusion
ACC is a rare tumor of high malignant potential, de-
riving from adrenal gland cortex. Morphologically (histo-
pathology and cytology), there is the problem of differen-
tial diagnosis from adenoma on the one hand, and from
renal cell carcinoma (RCC) and hepatocellular carcinoma
(HCC) on the other hand. Proliferation markers such as
Ki67 or DNA-ploidy help differentiate ACC from adeno-
ma, and cellular markers (alpha-fetoprotein, CD10, RCC
marker, vimentin, EMA, keratins 7 and 20, alpha-inhi-
bin, and polyclonal antibodies against carcinoembryonic
antigen (pCEA)) from RCC and HCC.
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CITOLO[KA SLIKA KARCINOMA NADBUBRE@NE @LIJEZDE: PRIKAZ SLU^AJA
S A @ E T A K
Adrenokortikalni karcinom (ACC) je maligni epitelni tumor stanica kore nadbubre`ne `lijezde. Polovina svih ACC-a
su hormonski aktivni. Kod 49 godi{nje bolesnice zbog poja~ane dlakavosti, dubljeg glasa i hipertenzije ultrazvu~nom
(US) obradom je na|ena solitarna tumorska tvorba desne nadbubre`ne `lijezde veli~ine 8 cm. Laboratorijskom obra-
dom utvr|eno je da se radi o hormonski aktivnom tumoru koji lu~i androgene (povi{ena vrijednost testosterona) u {to
se uklapa i klini~ka slika bolesti. Patohistolo{ka analiza ukazala je na postojanje adrenokortikalnog carcinoma (ACC)
koji prema Weissovoj klasifikaciji spada u »low risk« karcinom. Na redovnom US pregledu godinu dana kasnije dijagno-
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sticirana je tvorba (65x43 mm) u podru~ju donjeg pola desnog bubrega. Nalaz je potvr|en i kompjuteriziranom tomo-
grafijom te se ponovno pristupilo operativnom zahvatu. Eksploracijom se na|e sekundarizam u podru~ju velikog omen-
tuma koji ne infiltrira prile`e}e organe. Patohistolo{ka dijagnoza je odgovarala metastatskom ACC. Nakon 6 ciklusa
kemoterapije po EAP protokolu i 8 mjeseci iza drugog operativnog zahvata prisutni su pove}ani paraaortalni limfni
~vorovi i ~vor uz gornji pol desnog bubrega, koji je citolo{ki punktiran. Citolo{ki nalaz govorio je u prilog recidiva
osnovne maligne bolesti. ACC je rijedak tumor visokog malignog potencijala. Morfolo{ki (histopatolo{ki i citolo{ki)
pojavljuje se diferencijalno dijagnosti~ki problem prema adenomu s jedne strane i karcinomu bubrega i hepatocelu-
larnom karcinomu s druge strane. Potrebna je kombinirana evaluacija klini~kih pokazatelja, veli~ine ili te`ine tumora,
mikroskopskog izgleda, imunohistokemijskih i molekularnih geneti~kih podataka. Svrha ovog ~lanka je prikaz klini-
~kih i citomorfolo{kih osobitosti na{eg slu~aja karcinoma kore nadbubre`ne `lijezde koji je vrlo rijedak u citolo{koj
dijagnostici.
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